Related Experiment Video
Updated: Mar 23, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
15.7K
The therapeutic agents that target ATP-sensitive potassium channels
1School of Medicine, The Leeds Institute of Cardiovascular and Metabolic Medicine, Univiersity of Leeds, U.K. h.rubaiy@leeds.ac.uk
Acta Pharmaceutica (Zagreb, Croatia)
|April 1, 2016
Summary
ATP-sensitive potassium (K(ATP)) channels are vital drug targets for type-2 diabetes and cardiovascular diseases. Understanding their structure and allosteric regulation is key to developing new therapies.
Area of Science:
- Molecular biology
- Pharmacology
- Cardiovascular science
- Endocrinology
Background:
- ATP-sensitive potassium (K(ATP)) channels link cellular metabolism to electrical activity.
- These channels are critical for insulin secretion in pancreatic beta-cells.
- K(ATP) channels also play roles in neuroprotection and cardiovascular function.
Purpose of the Study:
- To review therapeutic agents targeting K(ATP) channels for diabetes and cardiovascular diseases.
- To highlight the structure and function of K(ATP) channels, focusing on the Kir6 and SUR subunits.
- To discuss the poorly understood allosteric communication pathways within K(ATP) channels.
Main Methods:
- Literature review of scientific publications.
- Analysis of existing data on K(ATP) channel structure and function.
- Synthesis of information on therapeutic agents and their mechanisms.
Main Results:
- K(ATP) channels are hetero-octamers of Kir6 and SUR subunits.
- SUR regulates channel gating via allosteric mechanisms in response to various ligands.
- Therapeutic agents targeting K(ATP) channels are established for diabetes and cardiovascular conditions.
Conclusions:
- K(ATP) channels are significant therapeutic targets for metabolic and cardiovascular disorders.
- Further research into allosteric communication is needed to optimize drug development.
- This review provides an overview of current therapeutic agents and their relevance.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
4.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.0K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
01:20Antiepileptic Drugs: Potassium Channel Activators
916
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
916
01:24Non-gated Ion Channels
8.9K
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
8.9K
01:24Non-gated Ion Channels
4.4K
4.4K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K